QuidelOrtho Executive and Leadership Team

Micah Young, the Chief Financial Officer at QuidelOrtho, directs all global fiscal operations and capital allocation strategies. Managing the financial health of the organization, the Chief Financial Officer oversees budgeting, investor relations, and long-term economic planning to support the development of clinical chemistry and immunodiagnostics equipment. Micah Young ensures rigorous compliance with international financial standards while driving profitability across North American and global markets. By optimizing resource distribution, the Chief Financial Officer enables the company to invest heavily in molecular and rapid antigen testing advancements. This leadership role involves constant collaboration with the Board to maintain fiscal transparency and sustainable growth. Through precise financial modeling and risk assessment, Young secures the capital necessary for expanding the manufacturing footprint. Ultimately, the Chief Financial Officer maintains the economic stability required for continuous innovation in the medical technology sector.

Jonathan Siegrist, the Executive VP, Research Development & Chief Technology Officer at QuidelOrtho, architects the future of diagnostic hardware and software platforms. Overseeing the entire R&D pipeline, the Executive VP, Research Development & Chief Technology Officer drives the creation of next-generation molecular and transfusion medicine tools. Jonathan Siegrist manages cross-functional engineering teams to accelerate product lifecycles from initial concept to clinical deployment. By integrating advanced automation into immunodiagnostics, the Executive VP, Research Development & Chief Technology Officer enhances the accuracy and speed of medical testing globally. This role requires deep technical expertise to navigate complex regulatory landscapes while maintaining a competitive edge in the medical technology market. Through strategic partnerships with academic and clinical institutions, Siegrist fosters an environment of rapid innovation. Ultimately, the Executive VP, Research Development & Chief Technology Officer ensures the company remains at the forefront of diagnostic science.

Nathaniel Sisitsky, the Chief Legal Officer at QuidelOrtho, manages all corporate governance, intellectual property protection, and regulatory compliance initiatives. Overseeing the legal framework for global operations, the Chief Legal Officer mitigates risk across the clinical chemistry and immunodiagnostics business units. Nathaniel Sisitsky directs complex litigation strategies and contract negotiations to safeguard the company's proprietary medical technology. By ensuring adherence to international healthcare regulations, the Chief Legal Officer protects the integrity of the brand in diverse global markets. This leadership role involves close coordination with the executive team to align corporate policies with evolving legal standards in the medical device industry. Through proactive legal counsel, Sisitsky supports the expansion of molecular and rapid antigen testing capabilities. Ultimately, the Chief Legal Officer provides the essential legal foundation for the company to operate securely and effectively on a worldwide scale.

Philip McLellan, the Chief Operations Officer at QuidelOrtho, executes the manufacturing and supply chain strategies required to deliver high-quality diagnostic equipment. Overseeing global production facilities, the Chief Operations Officer optimizes logistics for clinical chemistry, immunodiagnostics, and transfusion medicine products. Philip McLellan drives operational efficiency by implementing lean manufacturing processes across all regional hubs. By managing the end-to-end supply chain, the Chief Operations Officer ensures consistent product availability for healthcare providers worldwide. This leadership role involves coordinating with R&D and finance to scale production capacity in response to market demand for rapid antigen and molecular testing. Through rigorous quality control and process improvement, McLellan maintains the highest standards of operational excellence. Ultimately, the Chief Operations Officer supports the company's mission by ensuring that critical medical technology reaches clinical settings with maximum reliability and speed.